Browse by author
Lookup NU author(s): Dr Christian Thoma, Professor Chris Day, Professor Mike TrenellORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Non-alcoholic fatty liver disease is a serious and growing clinical problem. Despite lifestyle modification, i.e. diet and physical activity, being the recommended therapy, there are currently no systematic evaluations of its efficacy. This review applies a systematic approach to evaluating lifestyle modifications studied to date. Medline (Pubmed), Scopus, and the Cochrane Controlled Trials Register were searched for studies and study groups assessing the effect of diet, physical activity, and/or exercise modification in adult populations with non-alcoholic fatty liver disease. The outcome markers of interest were indicators of steatosis, histological evidence of inflammation and fibrosis, and glucose control/insulin sensitivity. We identified 23 studies for inclusion; seven had control groups, but only six were randomised. Eleven groups received diet-only interventions, two exercise-only, and 19 diet and physical activity/exercise. Studies consistently showed reductions in liver fat and/or liver aminotransferase concentration, with the strongest correlation being with weight reduction. Of the 5 studies reporting changes in histopathology, all showed a trend towards reduction in inflammation, in 2 this was statistically significant. Changes in fibrosis were less consistent with only one study showing a significant reduction. The majority of studies also reported improvements in glucose control/insulin sensitivity following intervention. However, study design, definition of disease, assessment methods, and interventions varied considerably across studies. Lifestyle modifications leading to weight reduction and/or increased physical activity consistently reduced liver fat and improved glucose control/insulin sensitivity. Limited data also suggest that lifestyle interventions may hold benefits for histopathology. Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
Author(s): Thoma C, Day CP, Trenell MI
Publication type: Review
Publication status: Published
Journal: Journal of Hepatology
Year: 2012
Volume: 56
Issue: 1
Pages: 255-266
Print publication date: 01/07/2011
ISSN (print): 0168-8278
ISSN (electronic): 1600-0641
Publisher: ELSEVIER SCIENCE BV
URL: http://dx.doi.org/10.1016/j.jhep.2011.06.010
DOI: 10.1016/j.jhep.2011.06.010
